30
nanotimes
Companies Facts
headquarters and laboratory facilities are located in Ann Arbor, Michigan.
http://www.nanobio.com
N
anoco Group plc (AIM: NANO), a world leader in the development and manufacture
of quantum dots, solar inks and other nanoma- terials, announced its preliminary results for the year ended July 31, 2010. Revenues in the year to July 31, 2010 increased by 47% to £2.94 million ($4.692m; 2009: £1.99m/$3,18m). The loss be- fore tax was £1.371 million ($2.188m; 2009: loss of £0.780m/$1.24m). Nanoco had cash, cash equi- valents and deposits of £5.68 million ($9.05m) end of July 2010 (July 2009: £6.59 million / $10.50m). The Company’s revenue is earned primarily through joint development agreements, with revenue being recognised as agreed performance milestones are achieved, and also from a material supply and licence agreement. In 2010, the Company signed a joint development agreement with major Japanese electronics company for LED backlighting of televi- sions, and with Tokyo Electron for a photovoltaic film, marking our first agreement in the solar power sector. In October 2010, Nanoco Group has achie- ved a key milestone in its solar photovoltaic agree- ment with Tokyo Electron triggering a payment. The milestone was triggered after Nanoco successfully de- veloped and supplied a bespoke solar ink, which has been used to create a nanomaterial thin film for the production of solar cells. The next step in the nine- month development phase of the agreement, which was signed in June 2010, is to continue to improve solar power efficiency.
Furthermore, Nanoco made significant progress towards mass production with new scale-up reac-
tors commissioned in Manchester producing quality material.
Michael Edelman, Chief Executive Officer, said: “Since joining AIM in May 2009, we have been focused on scaling up from the production of very small quantities of quantum dots to mass production so that customers can supply major end-use mar- kets. We made significant progress during the year in achieving this goal, including the appointment of Andrew Gooda as Manufacturing Director in January 2010. He has since developed a clear pathway to take us through the steps to mass production.
During the year, we have added a series of scale-up reactors in our Manchester headquarters. These re- actors are critical in the progression of the quantum dots from very small scale manufacture in the labora- tory to mass production. (…). Our customers are glo- bal corporations who expect suppliers to perform to accepted international standards. We are committed to exceeding the expected quality assurance stan- dards, and health, safety and environmental legisla- tion, both at Runcorn and in Manchester. We have recruited skilled staff who are currently developing and implementing the systems needed to ensure that all of our operations meet the highest standards.”
http://www.nanocotechnologies.com
O
ne year after the takeover from Siemens, the µsprint technology (formerly SISCAN) is fully
integrated at NanoFocus AG (N2F), Germany. Busi- ness with the ultrafast 3D-inline-inspection system has been so profitable that the acquisition costs are already amortized. The equipment order of an Asian international innovation leader of semiconductor components shows that the non-contact µsprint
10-10/11 :: October/November 2010
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79